Mr. Dvorak exited Zimmer Biomet in 2017 after 10 years as CEO. He spent 16 years total with the company. During his tenure, he grew revenues from $3.5 billion to $7.7 billion, spearheaded several acquisitions and launched Zimmer Biomet into the robot-assisted surgery market.
“Think’s industry-leading active robot technology provides an unparalleled opportunity to democratize robotic technology in orthopedics,” Mr. Dvorak said in the release. “The technology will deliver precision and implant flexibility to healthcare customers while at the same time enabling future, clinically relevant innovations for industry partners.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
